CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+9.19%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$709M
AUM Growth
+$709M
(-9.9%)
Cap. Flow
-$72.4M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
452
New
12
Increased
93
Reduced
281
Closed
40
Top Buys
| 1 |
NVIDIA
NVDA
|
$40.6M |
| 2 |
Apple
AAPL
|
$9.08M |
| 3 |
Applied Materials
AMAT
|
$5.39M |
| 4 |
Arista Networks
ANET
|
$5.26M |
| 5 |
Amphenol
APH
|
$5.14M |
Top Sells
| 1 |
Amgen
AMGN
|
$8.02M |
| 2 |
Adobe
ADBE
|
$7.95M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.6M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$6.84M |
| 5 |
Lam Research
LRCX
|
$5.23M |
Sector Composition
| 1 | Technology | 43.87% |
| 2 | Healthcare | 22.25% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Communication Services | 10.44% |
| 5 | Consumer Staples | 3.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Arcellx
ACLX
$3.87B
| $347K | 0.05% |
6,287
-3,890
| -38% | -$215K |
|
177
Xenon Pharmaceuticals
XENE
$3.03B
| $346K | 0.05% |
8,868
-5,652
| -39% | -$220K |
|
178
Amicus Therapeutics
FOLD
$2.43B
| $345K | 0.05% |
34,800
-21,951
| -39% | -$218K |
|
179
Twist Bioscience
TWST
$1.58B
| $337K | 0.05% |
6,841
-4,260
| -38% | -$210K |
|
|
SWTX
180
DELISTED
SpringWorks Therapeutics
SWTX
| $328K | 0.05% |
8,703
-5,491
| -39% | -$207K |
|
181
Thermo Fisher Scientific
TMO
$186B
| $327K | 0.05% |
591
-185
| -24% | -$102K |
|
182
Wells Fargo
WFC
$262B
| $326K | 0.05% |
5,484
-1,808
| -25% | -$107K |
|
183
PACCAR
PCAR
$52.5B
| $324K | 0.05% |
3,151
+788
| +33% | +$81.1K |
|
184
Autodesk
ADSK
$68.3B
| $321K | 0.05% |
1,296
+331
| +34% | +$81.9K |
|
185
Acadia Pharmaceuticals
ACAD
$4.38B
| $315K | 0.04% |
19,410
-12,244
| -39% | -$199K |
|
186
Copart
CPRT
$46.9B
| $313K | 0.04% |
5,786
+1,449
| +33% | +$78.5K |
|
187
Monster Beverage
MNST
$61.2B
| $313K | 0.04% |
6,263
+1,569
| +33% | +$78.4K |
|
188
IDEAYA Biosciences
IDYA
$2.23B
| $312K | 0.04% |
8,893
-5,454
| -38% | -$191K |
|
189
ADMA Biologics
ADMA
$4.1B
| $304K | 0.04% |
27,234
-16,636
| -38% | -$186K |
|
190
DexCom
DXCM
$29.1B
| $296K | 0.04% |
2,614
+652
| +33% | +$73.9K |
|
191
Accenture
ACN
$160B
| $296K | 0.04% |
974
-285
| -23% | -$86.5K |
|
192
Geron
GERN
$938M
| $295K | 0.04% |
69,683
-35,246
| -34% | -$149K |
|
193
Microchip Technology
MCHP
$34.3B
| $295K | 0.04% |
3,228
+791
| +32% | +$72.4K |
|
194
Rhythm Pharmaceuticals
RYTM
$6.92B
| $294K | 0.04% |
7,163
-4,398
| -38% | -$181K |
|
195
Ross Stores
ROST
$48.1B
| $293K | 0.04% |
2,016
+497
| +33% | +$72.2K |
|
196
Agios Pharmaceuticals
AGIO
$2.28B
| $288K | 0.04% |
6,670
-4,110
| -38% | -$177K |
|
197
Abbott
ABT
$229B
| $279K | 0.04% |
2,689
-797
| -23% | -$82.8K |
|
198
American Electric Power
AEP
$58.9B
| $278K | 0.04% |
3,169
+796
| +34% | +$69.8K |
|
199
Fortinet
FTNT
$58.9B
| $277K | 0.04% |
4,593
-9,349
| -67% | -$563K |
|
200
PTC Therapeutics
PTCT
$3.92B
| $276K | 0.04% |
9,012
-5,740
| -39% | -$176K |
|